Global and Japan Pneumococcal Vaccines Market Insights, Forecast to 2026

Global and Japan Pneumococcal Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pneumococcal Vaccines Product Introduction
1.2 Market Segments
1.3 Key Pneumococcal Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Type
1.4.2 PPSV 23
1.4.3 PCV 7/13
1.4.4 PCV 10
1.5 Market by Application
1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by Application
1.5.2 For Infants
1.5.3 For Children (2-10)
1.5.4 For Person (10-64)
1.5.5 For The Old (Above 65)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Pneumococcal Vaccines Revenue 2015-2026
2.1.2 Global Pneumococcal Vaccines Sales 2015-2026
2.2 Global Pneumococcal Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pneumococcal Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Pneumococcal Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pneumococcal Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pneumococcal Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pneumococcal Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Pneumococcal Vaccines Revenue Forecast by Region (2021-2026)
3 Global Pneumococcal Vaccines Competitor Landscape by Players
3.1 Global Top Pneumococcal Vaccines Sales by Manufacturers
3.1.1 Global Pneumococcal Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Pneumococcal Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pneumococcal Vaccines Manufacturers by Revenue
3.2.1 Global Pneumococcal Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pneumococcal Vaccines Revenue in 2019
3.2.5 Global Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pneumococcal Vaccines Price by Manufacturers
3.4 Global Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumococcal Vaccines Market Size by Type (2015-2020)
4.1.1 Global Pneumococcal Vaccines Sales by Type (2015-2020)
4.1.2 Global Pneumococcal Vaccines Revenue by Type (2015-2020)
4.1.3 Pneumococcal Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pneumococcal Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pneumococcal Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumococcal Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Pneumococcal Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pneumococcal Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pneumococcal Vaccines Market Size by Application (2015-2020)
5.1.1 Global Pneumococcal Vaccines Sales by Application (2015-2020)
5.1.2 Global Pneumococcal Vaccines Revenue by Application (2015-2020)
5.1.3 Pneumococcal Vaccines Price by Application (2015-2020)
5.2 Pneumococcal Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pneumococcal Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumococcal Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumococcal Vaccines Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Pneumococcal Vaccines Market Size YoY Growth 2015-2026
6.1.1 Japan Pneumococcal Vaccines Sales YoY Growth 2015-2026
6.1.2 Japan Pneumococcal Vaccines Revenue YoY Growth 2015-2026
6.1.3 Japan Pneumococcal Vaccines Market Share in Global Market 2015-2026
6.2 Japan Pneumococcal Vaccines Market Size by Players (International and Local Players)
6.2.1 Japan Top Pneumococcal Vaccines Players by Sales (2015-2020)
6.2.2 Japan Top Pneumococcal Vaccines Players by Revenue (2015-2020)
6.3 Japan Pneumococcal Vaccines Historic Market Review by Type (2015-2020)
6.3.1 Japan Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
6.3.2 Japan Pneumococcal Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 Japan Pneumococcal Vaccines Price by Type (2015-2020)
6.4 Japan Pneumococcal Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Pneumococcal Vaccines Sales Forecast by Type (2021-2026)
6.4.2 Japan Pneumococcal Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 Japan Pneumococcal Vaccines Price Forecast by Type (2021-2026)
6.5 Japan Pneumococcal Vaccines Historic Market Review by Application (2015-2020)
6.5.1 Japan Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
6.5.2 Japan Pneumococcal Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 Japan Pneumococcal Vaccines Price by Application (2015-2020)
6.6 Japan Pneumococcal Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Pneumococcal Vaccines Sales Forecast by Application (2021-2026)
6.6.2 Japan Pneumococcal Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 Japan Pneumococcal Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pneumococcal Vaccines Market Size YoY Growth 2015-2026
7.2 North America Pneumococcal Vaccines Market Facts & Figures by Country
7.2.1 North America Pneumococcal Vaccines Sales by Country (2015-2020)
7.2.2 North America Pneumococcal Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pneumococcal Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Pneumococcal Vaccines Market Facts & Figures by Country
8.2.1 Europe Pneumococcal Vaccines Sales by Country
8.2.2 Europe Pneumococcal Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pneumococcal Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pneumococcal Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Pneumococcal Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Pneumococcal Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pneumococcal Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Pneumococcal Vaccines Market Facts & Figures by Country
10.2.1 Latin America Pneumococcal Vaccines Sales by Country
10.2.2 Latin America Pneumococcal Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pneumococcal Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pneumococcal Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Pneumococcal Vaccines Sales by Country
11.2.2 Middle East and Africa Pneumococcal Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Pneumococcal Vaccines Products Offered
12.1.5 Pfizer Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Pneumococcal Vaccines Products Offered
12.2.5 Sanofi Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Description and Business Overview
12.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Pneumococcal Vaccines Products Offered
12.3.5 GSK Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Pneumococcal Vaccines Products Offered
12.4.5 Merck Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Corporation Information
12.5.2 Eli Lilly Description and Business Overview
12.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eli Lilly Pneumococcal Vaccines Products Offered
12.5.5 Eli Lilly Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Description and Business Overview
12.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AstraZeneca Pneumococcal Vaccines Products Offered
12.6.5 AstraZeneca Recent Development
12.7 Abera
12.7.1 Abera Corporation Information
12.7.2 Abera Description and Business Overview
12.7.3 Abera Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abera Pneumococcal Vaccines Products Offered
12.7.5 Abera Recent Development
12.8 S K Chemicals
12.8.1 S K Chemicals Corporation Information
12.8.2 S K Chemicals Description and Business Overview
12.8.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 S K Chemicals Pneumococcal Vaccines Products Offered
12.8.5 S K Chemicals Recent Development
12.9 Beijing Minhai Biotechnology
12.9.1 Beijing Minhai Biotechnology Corporation Information
12.9.2 Beijing Minhai Biotechnology Description and Business Overview
12.9.3 Beijing Minhai Biotechnology Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Products Offered
12.9.5 Beijing Minhai Biotechnology Recent Development
12.10 Baxter
12.10.1 Baxter Corporation Information
12.10.2 Baxter Description and Business Overview
12.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Baxter Pneumococcal Vaccines Products Offered
12.10.5 Baxter Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Pneumococcal Vaccines Products Offered
12.11.5 Pfizer Recent Development
12.12 Celgene Corporation
12.12.1 Celgene Corporation Corporation Information
12.12.2 Celgene Corporation Description and Business Overview
12.12.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Celgene Corporation Products Offered
12.12.5 Celgene Corporation Recent Development
12.13 Panacea Biotec
12.13.1 Panacea Biotec Corporation Information
12.13.2 Panacea Biotec Description and Business Overview
12.13.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Panacea Biotec Products Offered
12.13.5 Panacea Biotec Recent Development
12.14 Serum Institute of India
12.14.1 Serum Institute of India Corporation Information
12.14.2 Serum Institute of India Description and Business Overview
12.14.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Serum Institute of India Products Offered
12.14.5 Serum Institute of India Recent Development
12.15 Genentech
12.15.1 Genentech Corporation Information
12.15.2 Genentech Description and Business Overview
12.15.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Genentech Products Offered
12.15.5 Genentech Recent Development
12.16 Genocea Biosciences
12.16.1 Genocea Biosciences Corporation Information
12.16.2 Genocea Biosciences Description and Business Overview
12.16.3 Genocea Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Genocea Biosciences Products Offered
12.16.5 Genocea Biosciences Recent Development
12.17 ImmunoBiology
12.17.1 ImmunoBiology Corporation Information
12.17.2 ImmunoBiology Description and Business Overview
12.17.3 ImmunoBiology Sales, Revenue and Gross Margin (2015-2020)
12.17.4 ImmunoBiology Products Offered
12.17.5 ImmunoBiology Recent Development
12.18 Lupin
12.18.1 Lupin Corporation Information
12.18.2 Lupin Description and Business Overview
12.18.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Lupin Products Offered
12.18.5 Lupin Recent Development
12.19 Nuron Biotech
12.19.1 Nuron Biotech Corporation Information
12.19.2 Nuron Biotech Description and Business Overview
12.19.3 Nuron Biotech Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Nuron Biotech Products Offered
12.19.5 Nuron Biotech Recent Development
12.20 Biogen
12.20.1 Biogen Corporation Information
12.20.2 Biogen Description and Business Overview
12.20.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Biogen Products Offered
12.20.5 Biogen Recent Development
12.21 Valneva Austria
12.21.1 Valneva Austria Corporation Information
12.21.2 Valneva Austria Description and Business Overview
12.21.3 Valneva Austria Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Valneva Austria Products Offered
12.21.5 Valneva Austria Recent Development
12.22 Sinovac
12.22.1 Sinovac Corporation Information
12.22.2 Sinovac Description and Business Overview
12.22.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Sinovac Products Offered
12.22.5 Sinovac Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pneumococcal Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pneumococcal Vaccines Market Segments
Table 2. Ranking of Global Top Pneumococcal Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pneumococcal Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of PPSV 23
Table 5. Major Manufacturers of PCV 7/13
Table 6. Major Manufacturers of PCV 10
Table 7. Global Pneumococcal Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Pneumococcal Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Pneumococcal Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global Pneumococcal Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Pneumococcal Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pneumococcal Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Pneumococcal Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Pneumococcal Vaccines Sales Share by Manufacturers (2015-2020)
Table 15. Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Pneumococcal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccines as of 2019)
Table 17. Pneumococcal Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Pneumococcal Vaccines Price (2015-2020) (USD/Unit)
Table 20. Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Pneumococcal Vaccines Product Type
Table 22. Date of International Manufacturers Enter into Pneumococcal Vaccines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 25. Global Pneumococcal Vaccines Sales Share by Type (2015-2020)
Table 26. Global Pneumococcal Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Pneumococcal Vaccines Revenue Share by Type (2015-2020)
Table 28. Pneumococcal Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Pneumococcal Vaccines Sales Share by Type (2021-2026)
Table 30. Global Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 31. Global Pneumococcal Vaccines Sales Share by Application (2015-2020)
Table 32. Global Pneumococcal Vaccines Sales Share by Application (2021-2026)
Table 33. Global Pneumococcal Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Pneumococcal Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Pneumococcal Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan Pneumococcal Vaccines Sales (K Units) of Key Companies (2015-2020)
Table 37. Japan Pneumococcal Vaccines Sales Share by Company (2015-2020)
Table 38. Japan Pneumococcal Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan Pneumococcal Vaccines Sales (K Units) by Type (2015-2020)
Table 40. Japan Pneumococcal Vaccines Sales Share by Type (2015-2020)
Table 41. Japan Pneumococcal Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan Pneumococcal Vaccines Price (K Units) by Type (2015-2020)
Table 43. Japan Pneumococcal Vaccines Sales (K Units) by Type (2021-2026)
Table 44. Japan Pneumococcal Vaccines Sales Share by Type (2021-2026)
Table 45. Japan Pneumococcal Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan Pneumococcal Vaccines Revenue Share by Type (2021-2026)
Table 47. Japan Pneumococcal Vaccines Price (K Units) by Type (2021-2026)
Table 48. Japan Pneumococcal Vaccines Sales (K Units) by Application (2015-2020)
Table 49. Japan Pneumococcal Vaccines Sales Share by Application (2015-2020)
Table 50. Japan Pneumococcal Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan Pneumococcal Vaccines Sales (K Units) by Application (2021-2026)
Table 52. Japan Pneumococcal Vaccines Sales Share by Application (2021-2026)
Table 53. Japan Pneumococcal Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan Pneumococcal Vaccines Revenue Share by Application (2021-2026)
Table 55. North America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 56. North America Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 57. North America Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 59. Europe Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 60. Europe Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 61. Europe Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Pneumococcal Vaccines Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Pneumococcal Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Pneumococcal Vaccines Revenue Market Share by Region (2015-2020)
Table 67. Latin America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 68. Latin America Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Pneumococcal Vaccines Product
Table 79. Pfizer Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Product
Table 84. Sanofi Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GSK Product
Table 89. GSK Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck Product
Table 94. Merck Recent Development
Table 95. Eli Lilly Corporation Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Eli Lilly Product
Table 99. Eli Lilly Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. AstraZeneca Product
Table 104. AstraZeneca Recent Development
Table 105. Abera Corporation Information
Table 106. Abera Description and Business Overview
Table 107. Abera Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Abera Product
Table 109. Abera Recent Development
Table 110. S K Chemicals Corporation Information
Table 111. S K Chemicals Description and Business Overview
Table 112. S K Chemicals Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. S K Chemicals Product
Table 114. S K Chemicals Recent Development
Table 115. Beijing Minhai Biotechnology Corporation Information
Table 116. Beijing Minhai Biotechnology Description and Business Overview
Table 117. Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Beijing Minhai Biotechnology Product
Table 119. Beijing Minhai Biotechnology Recent Development
Table 120. Baxter Corporation Information
Table 121. Baxter Description and Business Overview
Table 122. Baxter Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Baxter Product
Table 124. Baxter Recent Development
Table 125. Biken Corporation Information
Table 126. Biken Description and Business Overview
Table 127. Biken Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Biken Product
Table 129. Biken Recent Development
Table 130. Celgene Corporation Corporation Information
Table 131. Celgene Corporation Description and Business Overview
Table 132. Celgene Corporation Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Celgene Corporation Product
Table 134. Celgene Corporation Recent Development
Table 135. Panacea Biotec Corporation Information
Table 136. Panacea Biotec Description and Business Overview
Table 137. Panacea Biotec Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Panacea Biotec Product
Table 139. Panacea Biotec Recent Development
Table 140. Serum Institute of India Corporation Information
Table 141. Serum Institute of India Description and Business Overview
Table 142. Serum Institute of India Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Serum Institute of India Product
Table 144. Serum Institute of India Recent Development
Table 145. Genentech Corporation Information
Table 146. Genentech Description and Business Overview
Table 147. Genentech Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Genentech Product
Table 149. Genentech Recent Development
Table 150. Genocea Biosciences Corporation Information
Table 151. Genocea Biosciences Description and Business Overview
Table 152. Genocea Biosciences Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Genocea Biosciences Product
Table 154. Genocea Biosciences Recent Development
Table 155. ImmunoBiology Corporation Information
Table 156. ImmunoBiology Description and Business Overview
Table 157. ImmunoBiology Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. ImmunoBiology Product
Table 159. ImmunoBiology Recent Development
Table 160. Lupin Corporation Information
Table 161. Lupin Description and Business Overview
Table 162. Lupin Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Lupin Product
Table 164. Lupin Recent Development
Table 165. Nuron Biotech Corporation Information
Table 166. Nuron Biotech Description and Business Overview
Table 167. Nuron Biotech Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Nuron Biotech Product
Table 169. Nuron Biotech Recent Development
Table 170. Biogen Corporation Information
Table 171. Biogen Description and Business Overview
Table 172. Biogen Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Biogen Product
Table 174. Biogen Recent Development
Table 175. Valneva Austria Corporation Information
Table 176. Valneva Austria Description and Business Overview
Table 177. Valneva Austria Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Valneva Austria Product
Table 179. Valneva Austria Recent Development
Table 180. Sinovac Corporation Information
Table 181. Sinovac Description and Business Overview
Table 182. Sinovac Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 183. Sinovac Product
Table 184. Sinovac Recent Development
Table 185. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 186. Key Challenges
Table 187. Market Risks
Table 188. Main Points Interviewed from Key Pneumococcal Vaccines Players
Table 189. Pneumococcal Vaccines Customers List
Table 190. Pneumococcal Vaccines Distributors List
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccines Product Picture
Figure 2. Global Pneumococcal Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 7/13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. For Infants
Figure 8. For Children (2-10)
Figure 9. For Person (10-64)
Figure 10. For The Old (Above 65)
Figure 11. Pneumococcal Vaccines Report Years Considered
Figure 12. Global Pneumococcal Vaccines Market Size 2015-2026 (US$ Million)
Figure 13. Global Pneumococcal Vaccines Sales 2015-2026 (K Units)
Figure 14. Global Pneumococcal Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Pneumococcal Vaccines Sales Market Share by Region (2015-2020)
Figure 16. Global Pneumococcal Vaccines Sales Market Share by Region in 2019
Figure 17. Global Pneumococcal Vaccines Revenue Market Share by Region (2015-2020)
Figure 18. Global Pneumococcal Vaccines Revenue Market Share by Region in 2019
Figure 19. Global Pneumococcal Vaccines Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Pneumococcal Vaccines Revenue in 2019
Figure 21. Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Figure 23. Global Pneumococcal Vaccines Sales Market Share by Type in 2019
Figure 24. Global Pneumococcal Vaccines Revenue Market Share by Type (2015-2020)
Figure 25. Global Pneumococcal Vaccines Revenue Market Share by Type in 2019
Figure 26. Global Pneumococcal Vaccines Market Share by Price Range (2015-2020)
Figure 27. Global Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Figure 28. Global Pneumococcal Vaccines Sales Market Share by Application in 2019
Figure 29. Global Pneumococcal Vaccines Revenue Market Share by Application (2015-2020)
Figure 30. Global Pneumococcal Vaccines Revenue Market Share by Application in 2019
Figure 31. Japan Pneumococcal Vaccines Sales Growth Rate 2015-2026 (K Units)
Figure 32. Japan Pneumococcal Vaccines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Japan Pneumococcal Vaccines Market Share in Global Market 2015-2026
Figure 34. Japan 5 and 10 Largest Pneumococcal Vaccines Players Market Share by Revenue in Pneumococcal Vaccines in 2019
Figure 35. Japan Pneumococcal Vaccines Revenue Share by Type (2015-2020)
Figure 36. Japan Pneumococcal Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 37. Japan Pneumococcal Vaccines Revenue Share by Application (2015-2020)
Figure 38. Japan Pneumococcal Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 42. North America Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 43. U.S. Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 48. Europe Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 50. Europe Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 51. Germany Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Germany Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. France Pneumococcal Vaccines Revenue Gro

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs